Zohar is an entrepreneur who has launched several successful businesses. He has founded, advised and invested in numerous companies including 911ENABLE™ which he led from start-up to its acquisition by West Telecom in 2014. Zohar has been recognized as a top leader and innovator by a number of sources, including Deloitte Technology Fast 50™ fastest growing technology companies in Canada. He is actively involved with early-stage companies as an advisor and board member. He is also a certified commercial pilot.
Nicholas Sosiak is a Chartered Professional Accountant with an entrepreneurial spirit and passion for the Cannabis industry. As Chief Financial Officer of Cannara, Nicholas is responsible for overseeing the company’s finances and treasury and is a key decision maker in all facets of the company from genetic selection, marketing and branding, product formulation, sales, investor, and public relations. Prior to working in the industry, he practiced auditing at two of the big five accounting firms and worked as Vice President of Finance and Accounting for Dundee 360 Real Estate Corporation, a subsidiary of Dundee Corporation and a publicly traded company listed on the TSX.
Avi has been in the information technology industry for over 20 years. He specializes in innovation and cutting edge technologies. Prior to Cannara, Avi has patented 911 software solutions currently being used by many Fortune 500 companies such as Microsoft, Boeing, Disney and the US Department of Defense. Avi oversees Cannara’s journey to be a leader in the cannabis industry for automation and quality control.
Noemi is a Chartered Professional Accountant and have 8 years of audit experience in small to large-size public and private companies in the mining, commodity and manufacturing industries. Through those years, she gained valuable expertise in financial reporting, accounting and management. She became a key asset internally and for her clients. After her career in the audit practice as a senior manager at PwC, Noemi joined Cannara Biotech Inc. as Director of Finance and worked her way up to Vice-President of Finance and Accounting.
Anthony is an accomplished business leader specializing in pharmaceutical compliance and operations. With 15 years of experience working for both public and private companies, he has managed various portfolios of products ranging from controlled drugs and substances, to medical devices, sterile injectables and natural health products. Anthony joined Cannara Biotech in 2018, where he oversaw the buildout of phase one of the Farnham facility, and secured Cannara’s Cultivation, Processing, Medical Sales and Adult Recreational Sales licenses from Health Canada. He holds a BSc in biochemistry and an International MBA.
Brian brings industry experience having served as a senior member of the legal team at Canopy Growth, one of Canada’s most established cannabis producers. Prior to his time in the cannabis industry, Brian served as a corporate associate at Stikeman Elliott with a focus on mergers and acquisitions, and also held a role at Robinson Sheppard Shapiro where he excelled in litigation and dispute resolution, resulting in an extremely well rounded legal knowledge base. Brian’s academic career brought him to Belgium and Singapore, and he obtained both a civil and common law degree from McGill University, eventually becoming a member of both the Quebec and Ontario bar.
Scott joins the Cannara team with extensive global brand strategy experience in the highly regulated pharmaceutical and cannabis industries, holding a PhD in Genetics and an Executive MBA. Growing brand awareness and brand loyalty with a broad skill set, over the past 4 years Scott has supported two of Canada’s largest cannabis producers (Canopy Growth and HEXO) on initiatives covering product development, category management, clinical research, and continuing medical education. Scott now leads the marketing and sales efforts as Cannara enters new markets across Canada.
Nicolas comes to Cannara with over twenty years of pharmaceutical industry leadership experience with positions at Endoceutics Pharma Inc., Bayer Inc and Merck Canada where he distinguished himself by leading large-scale projects such as ERP system implementations, operating costs reductions, and supply chain optimizations. Prior to joining Cannara, Mr. Dupuis was responsible for managing four manufacturing sites in North America and Europe and developed plans for launching new products on the European market, Middle East and Asia. Mr. Dupuis holds a BSc degree and a Master’s degree in Business Administration.